Neal M. Davies

Articles in Scholarly Journals [Incomplete List]

  1. Phytopreventative effects ofGynostemma pentaphyllum against acute Indomethacin-induced gastrointestinal and renal toxicity in rats
    Phytotherapy Research, vol. 21, no. 6, pp. 523–530, 2007
  2. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(e-caprolactone) micelles of rapamycin
    Cancer Chemotherapy and Pharmacology, vol. 61, no. 1, pp. 133–144, 2007
  3. Stereospecific high-performance liquid chromatographic analysis of eriodictyol in urine
    Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 1, pp. 255–262, 2007
  4. High-performance liquid chromatographic analysis of pterostilbene in biological fluids using fluorescence detection
    Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 1, pp. 250–254, 2007
  5. Methods of analysis and separation of chiral flavonoids
    Journal of Chromatography B, vol. 848, no. 2, pp. 159–181, 2007
  6. Physiological and biochemical responses of fruit exocarp of tomato (Lycopersicon esculentum Mill.) mutants to natural photo-oxidative conditions
    Journal of Experimental Botany, vol. 57, no. 9, pp. 1933–1947, 2006
  7. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats
    Journal of Pharmacy and Pharmacology, vol. 58, no. 11, pp. 1443–1450, 2006
  8. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal
    Expert Review of Neurotherapeutics, vol. 6, no. 11, pp. 1643–1655, 2006
  9. Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety
    Expert Opinion on Pharmacotherapy, vol. 6, no. 12, pp. 2117–2140, 2005
  10. Mycophenolate Sodium Does Not Reduce the Incidence of GI Adverse Events Compared with Mycophenolate Mofetil
    American Journal of Transplantation, vol. 5, no. 5, pp. 1164–1164, 2005
  11. Journal of Agricultural and Food Chemistry, vol. 53, no. 24, pp. 9536–9543, 2005
  12. Stereospecific high-performance liquid chromatographic analysis of hesperetin in biological matrices
    Journal of Pharmaceutical and Biomedical Analysis, vol. 37, no. 3, pp. 591–595, 2005
  13. Determination and assay validation of pinosylvin in rat serum: application to drug metabolism and pharmacokinetics
    Journal of Pharmaceutical and Biomedical Analysis, 2005
  14. Stereospecific high-performance liquid chromatographic analysis of naringenin in urine
    Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 1-2, pp. 164–169, 2005
  15. Direct high-performance liquid chromatographic analysis of -tocopheryl acid succinate and derivatives
    Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 1-2, pp. 33–38, 2005
  16. Pharmacokinetics and tissue distribution ofd-alpha-tocopheryl succinate formulations following intravenous administration in the rat
    Biopharmaceutics & Drug Disposition, vol. 26, no. 5, pp. 195–203, 2005
  17. Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation
    Biomedical Chromatography, vol. 18, no. 8, pp. 486–491, 2004
  18. Degradation and metabolism of mometasone furoate in humans: Influence of reversible, sequential metabolism, and ionic strength
    Journal of Pharmaceutical Sciences, vol. 93, no. 12, pp. 2877–2880, 2004
  19. High-performance liquid chromatographic analysis of a selective cyclooxygenase-1 inhibitor SC-560 in rat serum: application to pharmacokinetic studies
    Journal of Pharmaceutical and Biomedical Analysis, vol. 35, no. 5, pp. 1143–1147, 2004
  20. A novel method for assessing dissolution of aerosol inhaler products
    International Journal of Pharmaceutics, vol. 255, no. 1-2, pp. 175–187, 2003
  21. Degradation kinetics of mometasone furoate in aqueous systems
    International Journal of Pharmaceutics, vol. 259, no. 1-2, pp. 129–141, 2003
  22. Mometasone furoate degradation and metabolism in human biological fluids and tissues
    Biopharmaceutics & Drug Disposition, vol. 24, no. 8, pp. 321–333, 2003
  23. Stereospecific high-performance liquid chromatographic analysis of flurbiprofen: application to pharmacokinetic studies
    Journal of Pharmaceutical and Biomedical Analysis, vol. 33, no. 1, pp. 95–100, 2003
  24. Chemical Research in Toxicology, vol. 16, no. 1, pp. 28–37, 2003
  25. Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum
    Journal of Chromatography B, vol. 796, no. 2, pp. 225–231, 2003
  26. Influence of single versus multiple actuations on the particle size distribution of beclometasone dipropionate metered-dose inhalers
    Journal of Pharmacy and Pharmacology, vol. 55, no. 8, pp. 1055–1061, 2003
  27. Kinetics of metabolism and degradation of mometasone furoate in rat biological fluids and tissues
    Journal of Pharmacy and Pharmacology, vol. 55, no. 5, pp. 617–630, 2003
  28. Pharmacokinetics of Rofecoxib
    Clinical Pharmacokinetics, vol. 42, no. 6, pp. 545–556, 2003
  29. Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
    Coordination Chemistry Reviews, vol. 232, no. 1-2, pp. 95–126, 2002
  30. High-performance liquid chromatographic analysis of mometasone furoate and its degradation products Application to in vitro degradation studies
    Journal of Pharmaceutical and Biomedical Analysis, vol. 26, no. 2, pp. 313–319, 2001
  31. Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis
    Expert Opinion on Pharmacotherapy, vol. 2, no. 1, pp. 139–152, 2001
  32. Influence of Respiratory Spacer Devices on Aerodynamic Particle Size Distribution and Fine Particle Mass of Beclomethasone from Metered-Dose Inhalers
    Journal of Aerosol Medicine, vol. 14, no. 4, pp. 477–485, 2001
  33. Misoprostol Therapeutics Revisited
    Pharmacotherapy: Official Journal of the American College of Clinical Pharmacy, vol. 21, no. 1, pp. 60–73, 2001
  34. Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
    Clinical Pharmacokinetics, vol. 38, no. 3, pp. 225–242, 2000
  35. Propri??t??s et sp??cificit??s de la nabum??tone
    Drugs, vol. 59, no. Special Issue 1, pp. 25–33, 2000
  36. Clinical Pharmacokinetics of Meloxicam
    Clinical Pharmacokinetics, vol. 36, no. 2, pp. 115–126, 1999
  37. Clinical Pharmacokinetics and Pharmacodynamics of Bromfenac
    Clinical Pharmacokinetics, vol. 36, no. 6, pp. 399–408, 1999
  38. Stereospecific pharmacokinetics and toxicodynamics of ketorolac after oral administration of the racemate and optically pure enantiomers to the rat
    Chirality, vol. 11, no. 3, pp. 201–205, 1999
  39. Clinical Pharmacokinetics of Ibuprofen
    Clinical Pharmacokinetics, vol. 34, no. 2, pp. 101–154, 1998
  40. Clinical Pharmacokinetics of Lornoxicam
    Clinical Pharmacokinetics, vol. 34, no. 6, pp. 421–428, 1998
  41. Clinical Pharmacokinetics of Oxaprozin
    Clinical Pharmacokinetics, vol. 35, no. 6, pp. 425–436, 1998
  42. Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability
    Alimentary Pharmacology and Therapeutics, vol. 12, no. 4, pp. 303–320, 1998
  43. TOXICOKINETICS OF INDOMETHACIN-INDUCED INTESTINAL PERMEABILITY IN THE RAT
    Pharmacological Research, vol. 35, no. 6, pp. 499–504, 1997
  44. Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: New insights into an old problem
    Journal of Gastroenterology, vol. 32, no. 1, pp. 127–133, 1997
  45. Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation
    Gastroenterology, vol. 112, no. 1, pp. 109–117, 1997
  46. Alendronate induces gastric injury and delays ulcer healing in rodents
    Life Sciences, vol. 62, no. 1, pp. 77–91, 1997
  47. Methods of analysis of chiral non-steroidal anti-inflammatory drugs
    Journal of Chromatography B: Biomedical Sciences and Applications, vol. 691, no. 2, pp. 229–261, 1997
  48. Pharmaceutical Research, vol. 14, no. 11, pp. 1597–1600, 1997
  49. Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability
    Journal of Pharmaceutical Sciences, vol. 85, no. 11, pp. 1170–1173, 1996
  50. Nonsteroidal antiinflammatory drug–induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritis
    Arthritis & Rheumatism, vol. 39, no. 2, pp. 321–324, 1996
  51. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine
    Diseases of the Colon & Rectum, vol. 38, no. 12, pp. 1311–1321, 1995
  52. Pharmaceutical Research, vol. 12, no. 11, pp. 1733–1736, 1995
  53. Pharmaceutical Research, vol. 11, no. 11, pp. 1652–1656, 1994
  54. Rationale for the development of stereochemically pure enantiomers: Are theR enantiomers of chiral nonsteroidal anti-inflammatory drugs inactive?
    Journal of Pharmaceutical Sciences, vol. 83, no. 6, pp. 911–912, 1994